Havencrest Healthcare Partners, L.P.'s Form 4 filing
Starling Oncology, Inc. (DFPH) · filed Jan 30, 2024
- Accession no.
- 0000950170-24-009050
- Filed
- Jan 30, 2024, 7:07 PM ET
- Trade date
- Jan 29, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $18.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Havencrest Healthcare Partners, L.P.CIK 0001705748 | 10% Owner |
| Toi HC I, LLCCIK 0001892154 | 10% Owner |
| Havencrest Healthcare Partners GP, LLCCIK 0001893722 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | Common stock | SSaleDisposed | −8,637 | $2.12 | −$18,310.44 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.